Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garnero

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
Bone|May 1, 1997
Short-term effects of corticosteroids on trabecular bone remodeling in old ewesP Chavassieux, A Buffet, P Vergnaud, et al.
Osteoarthritis and Cartilage|June 15, 2015
Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY studyJ C Rousseau, E Sornay-Rendu, C Bertholon, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2014
Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY studyJ C Rousseau, E Sornay-Rendu, C Bertholon, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2005
Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral densityP Garnero, F Munoz, O Borel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 27, 1998
Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY studyT R Eccleshall, P Garnero, C Gross, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2016
Response to the Letter: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?P Chavassieux, N Portero-Muzy, J P Roux, et al.
Arthritis and Rheumatism|March 4, 1998
Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's diseaseP Garnero, E Gineyts, A V Schaffer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2001
The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis FoundationP D Delmas, R Eastell, P Garnero, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 25, 2012
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY studyP Garnero, E Sornay-Rendu, F Munoz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1994
Markers of bone turnover in hyperthyroidism and the effects of treatmentP Garnero, V Vassy, A Bertholin, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Bone|May 1, 1997
Short-term effects of corticosteroids on trabecular bone remodeling in old ewesP Chavassieux, A Buffet, P Vergnaud, et al.
Osteoarthritis and Cartilage|June 15, 2015
Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY studyJ C Rousseau, E Sornay-Rendu, C Bertholon, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2014
Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY studyJ C Rousseau, E Sornay-Rendu, C Bertholon, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2005
Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral densityP Garnero, F Munoz, O Borel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 27, 1998
Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY studyT R Eccleshall, P Garnero, C Gross, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2016
Response to the Letter: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?P Chavassieux, N Portero-Muzy, J P Roux, et al.
Arthritis and Rheumatism|March 4, 1998
Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's diseaseP Garnero, E Gineyts, A V Schaffer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2001
The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis FoundationP D Delmas, R Eastell, P Garnero, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 25, 2012
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY studyP Garnero, E Sornay-Rendu, F Munoz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1994
Markers of bone turnover in hyperthyroidism and the effects of treatmentP Garnero, V Vassy, A Bertholin, et al.
Pageof 15